SCHEMBL13260737

SCHEMBL13260737

Cc1ccc(CN2CCC(C)C2)c(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.45
▸ TSHR P16473 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ACHE P22303 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ PDE2A O00408 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18908934 0.85 DDR1 (0.47) NR1H2DDR1
SCHEMBL15381987 0.84 DDR1 (0.49) NR1H2DDR1
SCHEMBL17320456 0.82 NR1H2 (0.49) NR1H2ACHEKDM4EALDH1A1MEN1
SCHEMBL14315490 0.82 MLNR (0.52) NR1H2KDM4EALDH1A1MEN1KMT2A
SCHEMBL18403054 0.81 DDR1 (0.47) DDR1
SCHEMBL17191552 0.81 ALDH1A1 (0.52) NR1H2TSHRSMN1; SMN2KDM4EALDH1A1
SCHEMBL24565992 0.80 NR1H2 (0.46) NR1H2KDM4EALDH1A1MEN1KMT2A
SCHEMBL12426532 0.80 NR1H2 (0.55) NR1H2SMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL19634231 0.79 PDE2A (0.48) TSHRNPC1RAB9ASMN1; SMN2ACHE
SCHEMBL19634249 0.79 PDE2A (0.48) TSHRNPC1RAB9ASMN1; SMN2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010092489-A1 DERIVATIVES OF AZAINDOLES AS INHIBITORS OF PROTEIN KINASES ABL AND SRC NOVA DECISION (FR) 2010-08-19 — — WO disclosed
Send feedback